Pilotní studie identifikace prognostických markerů u pacientů s kolorektálním karcinomem analýzou profilů genové exprese.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Identification of colorectal cancer prognostic markers by gene expression profiles analysis: pilot study
Authors

SLABÝ Ondřej GARAJOVÁ Ingrid SVOBODA Marek FABIAN Pavel SVOBODA Miroslav SROVNAL Josef KOCÁKOVÁ Ilona ŠEFR Roman JECH Z. HOCH Jiří VYZULA Rostislav

Year of publication 2006
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.linkos.cz/vzdelavani/ko_zobraz.php?i=2&ID=33&id[]=693&Submit=Zobrazit
Field Oncology and hematology
Keywords olorectal cancer; DNA microarray technology; gene expression profiles; pathogenesis; prognosis
Description Colorectal cancer (CRC) is one of the most common malignancies. Unfortunately a significant proportion of surgically cured patients in the early stage of the disease develop progression and die from the disease. Twelve patients who had histologically confirmed left-sided colon adenocarcinoma with a volume fraction showing at least 70% of malignant tumor cells were included. Only stage II-III patients according to IUCC with no prior chemotherapy or radiotherapy were eligible for the study. Six patients were poor prognosis cases with disease free survival (DFS) lower then 36 month and six were good prognosis cases with DFS>36 month. Relative gene expression levels of 128 genes potentially involved in cancer progression and dissemination were obtained by low-density oligonucleotide microarrays (SuperArray Bioscience Corp., Bethesda, MD) from 12 primary colon cancer samples. Gene expression data analysis based on the SAM and t-test (p = 0,01) methods identified 10 genes with significantly different expression in primary tumors of patients with poor prognosis. Our preliminary data suggest that oligonucleotide microarray technology should contribute to a better understanding of the progression of colorectal cancer, and facilitate prediction of their metastatic potential.

You are running an old browser version. We recommend updating your browser to its latest version.

More info